December 18, 2013

Actelion has launched a topical gel used to treat a kind of skin cancer, the company said.

December 18, 2013

The Food and Drug Administration and the European Medicines Agency will share data about studies meant to show whether generic drugs are equivalent to their branded counterparts, under a joint program announced Wednesday.

December 18, 2013

AmerisourceBergen on Wednesday announced a CMS Star measure improvement initiative for members of the Good Neighbor Pharmacy network, a group of more than 3,200 independent pharmacies across the nation.

December 18, 2013

The Food and Drug Administration has approved a new drug made by GlaxoSmithKline and Theravance for treating chronic obstructive pulmonary disease, the agency said Wednesday.

December 18, 2013

Higi, a consumer-focused health engagement company, has acquired fitness gamification-based platform Earndit.

December 18, 2013

Lupin has launched a generic drug for treating HIV, following its victory in a patent-infringement suit in federal court, the Indian drug maker said Wednesday.

December 18, 2013

A new study has found a significant increase in the number of high school students who report having abused a common prescription drug for attention deficit hyperactivity disorder, even as abuse of other prescription drugs has decreased or remained low.

December 18, 2013

The U.S. healthcare system saved $217 billion in 2012 thanks to the use of generic drugs, according to a new report by a generic drug industry trade group.

December 18, 2013

Mylan has acquired rights to an experimental respiratory drug made by Pfizer, Mylan said.

December 18, 2013

Four school districts have won a competition sponsored by Mylan to raise awareness about dangerous allergic reactions, the company said.

December 18, 2013

Perrigo has finalized its acquisition of Elan Corp., Perrigo said Wednesday.

December 18, 2013

Respiratory Syncytial Virus appears to cause milder illness than influenza in adults age 50 or older, researchers at Marshfield Clinic Research Foundation announced,

December 17, 2013

Amneal Pharmaceuticals has launched a new treatment for gastroesophageal reflux disease under a partnership with a South Korean drug maker.

December 17, 2013

Greenstone has launched a version of a drug used to treat fungal infections, the company said.

December 17, 2013

To help CPG manufacturers and retailers identify and leverage the varying shopper beliefs about health and nutrition, IRI has released the first NutriLink segmentation study, which classifies U.S. consumers into six groups based on their behavior and attitudes toward health, diet and nutrition, as well as their demographics.

December 17, 2013

Three organizations will receive part of $1.3 million in funding that German drug maker Merck KGaA and the National Multiple Sclerosis Society are distributing for MS research.

December 17, 2013

Mylan and a partnering company will be able to sell a generic version of a cancer drug starting in summer 2015, under a court settlement announced Tuesday.

December 17, 2013

Price Chopper Supermarkets and CDPHP have joined forces to provide community access to health services and screenings at new health stations,

December 17, 2013

Forty blockbuster drugs will use patent exclusivity in the United States between this year and 2020, according to a new study.

December 17, 2013

Consumer advocates worry that misconceptions and fears about the safety and effectiveness of flu vaccines are hindering efforts to get children vaccinated, according to a new survey.

December 16, 2013

A redesigned version of an injector pen used to treat infertility is available for distribution in the United States, the manufacturer said.

December 16, 2013

Endo Health Solutions will acquire the maker of a patch used to treat migraines that received Food and Drug Administration approval at the beginning of this year.

December 16, 2013

Everett Labs has acquired Quinnova Pharmaceuticals from Amneal Enterprises, Everett said Monday.

December 16, 2013

The Food and Drug Administration may require makers of antibacterial soaps to perform clinical trials to show their products are better at preventing infections and disease than ordinary soaps.